Aytu Biopharma (NasdaqCM:AYTU) Q4 2026 Earnings call September 22, 2026 04:30 PM ET Speaker0Please note this conference is being recorded. I will now turn the conference over to your host, Robert Blum with Lytham Partners. You may begin.Speaker1All right. Thank you, and good afternoon, everyone. As the operator indicated, during today's call, we will be discussing Aytu BioPharma's fiscal 2026 fourth quarter and full year operational and financial results for the period ended June 30, 2026. Joining us on tod ...

Aytu BioPharma Reports Fiscal 2026 Full Year and Fourth Quarter Operational and Financial Results Aytu BioPharma Reports Fiscal 2026 Full Year and Fourth Quarter Operational and Financial Results Tuesday, 22 September 2026 04:05 PM Earnings Fourth quarter fiscal 2026 net revenue increased 6.4% to $16.1 million from $15.1 million in the prior-year quarter Fourth quarter fiscal 2026 Adjusted EBITDA of $0.5 million EXXUA net revenue of $6.6 million in fiscal 2026, including $3.9 million in the fourth quarter, ...